https://arab.news/9mbqc
Dr. Faisal Abdullah Al-Saif has been CEO of the Abha-based King Faisal Medical City since 2021.
Al-Saif, who worked as an adviser at the Health Ministry鈥檚 vision realization office for almost 10 months in 2019, has also been vice president of the central business unit at the Health Holding Co. in Riyadh since 2019.
He covered the company鈥檚 Eastern Province business unit from October 2019 to December 2020. He is currently covering the company鈥檚 same unit in the southern region.
From 2006 to 2008, Al-Saif was deputy director of the general surgery residency program at the King Saud University Medical City.
For more than five years from 2007, he worked as the supervisor of the internship office at the KSUMC鈥檚 college of medicine.
He was vice dean for academic affairs at the same college for almost three years from 2012. Before that, Al-Saif, who is chairing the scientific committee of the Saudi Center of Organ Transplantation, headed the general surgery department at KSUMC for over a year. From September 2015 to January 2019, he served as the chief medical officer at KSUMC.
Al-Saif, professor and consultant of HPB and transplant surgery at King Saud University, has occupied a number of academic positions, such as directing the future scientist program at Prince Naif Research Institute, and the beta-cell unit at KSU鈥檚 diabetes center.
Al-Saif received a bachelor鈥檚 degree in medicine and surgery from KSU in 1996. He then joined a two-year internship and training program at the King Khalid University Hospital in Riyadh.
He also attended a five-year general surgery residency training program at the University of Manitoba, Canada, beginning in 1998, after which he obtained a fellowship in the Royal College of Physicians and Surgeons.